These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8393895

  • 1. Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fenfluramine or placebo to healthy subjects.
    Gorard DA, Taylor TM, Medbak SH, Perry LA, Libby GW, Farthing MJ.
    Int Clin Psychopharmacol; 1993; 8(2):123-8. PubMed ID: 8393895
    [Abstract] [Full Text] [Related]

  • 2. Hormonal responses to d- and d,l-fenfluramine in healthy human subjects.
    Coccaro EF, Kavoussi RJ, Cooper TB, Hauger RL.
    Neuropsychopharmacology; 1996 Dec; 15(6):595-607. PubMed ID: 8946434
    [Abstract] [Full Text] [Related]

  • 3. Endocrine and amine responses to D,L-fenfluramine in normal subjects.
    Mitchell PB, Smythe GA.
    Psychiatry Res; 1991 Nov; 39(2):141-53. PubMed ID: 1686811
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Stress hormone dysregulation at rest and after serotonergic stimulation among alcohol-dependent men with extended abstinence and controls.
    Anthenelli RM, Maxwell RA, Geracioti TD, Hauger R.
    Alcohol Clin Exp Res; 2001 May; 25(5):692-703. PubMed ID: 11411461
    [Abstract] [Full Text] [Related]

  • 7. Differences between morning and afternoon hormonal responses to D-fenfluramine in healthy humans.
    Monteleone P, Bortolotti F, Orazzo C, Serino I, Maj M.
    Psychoneuroendocrinology; 1997 Feb; 22(2):79-87. PubMed ID: 9149330
    [Abstract] [Full Text] [Related]

  • 8. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
    Cleare AJ, Murray RM, O'Keane V.
    Neuropsychopharmacology; 1996 May; 14(5):349-54. PubMed ID: 8703303
    [Abstract] [Full Text] [Related]

  • 9. Oral D-fenfluramine and neuroendocrine challenge: problems with the 30 mg dose in men.
    Goodwin GM, Murray CL, Bancroft J.
    J Affect Disord; 1994 Feb; 30(2):117-22. PubMed ID: 8201126
    [Abstract] [Full Text] [Related]

  • 10. Lack of effect of hydrocortisone treatment on d-fenfluramine-mediated prolactin release.
    Young AH, Rue J, Odontiadis J, Cowen PJ.
    Psychopharmacology (Berl); 1998 Mar; 136(2):198-200. PubMed ID: 9551777
    [Abstract] [Full Text] [Related]

  • 11. Thyroid axis activity and serotonin function in major depressive episode.
    Duval F, Mokrani MC, Bailey P, Correa H, Diep TS, Crocq MA, Macher JP.
    Psychoneuroendocrinology; 1999 Oct; 24(7):695-712. PubMed ID: 10451906
    [Abstract] [Full Text] [Related]

  • 12. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [Abstract] [Full Text] [Related]

  • 13. Seasonal variation in plasma prolactin response to D-fenfluramine in healthy subjects.
    Monteleone P, La Rocca A, Fuschino A, Bortolotti F, Maj M.
    Psychoneuroendocrinology; 1999 Feb; 24(2):201-8. PubMed ID: 10101728
    [Abstract] [Full Text] [Related]

  • 14. Diminished serotonin-mediated prolactin responses in nondepressed stroke patients compared with healthy normal subjects.
    Ramasubbu R, Flint A, Brown G, Awad G, Kennedy S.
    Stroke; 1998 Jul; 29(7):1293-8. PubMed ID: 9660375
    [Abstract] [Full Text] [Related]

  • 15. The effects of d- and l-fenfluramine (and their interactions with d-amphetamine) on cortisol secretion.
    Feeney S, Goodall E, Silverstone T.
    Int Clin Psychopharmacol; 1993 Jul; 8(3):139-42. PubMed ID: 8263310
    [Abstract] [Full Text] [Related]

  • 16. Hormone responses to fenfluramine and placebo challenge in endogenous depression.
    Lichtenberg P, Shapira B, Gillon D, Kindler S, Cooper TB, Newman ME, Lerer B.
    Psychiatry Res; 1992 Aug; 43(2):137-46. PubMed ID: 1410069
    [Abstract] [Full Text] [Related]

  • 17. HPA-axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls.
    Maes M, D'Hondt P, Suy E, Minner B, Vandervorst C, Raus J.
    Prog Neuropsychopharmacol Biol Psychiatry; 1991 Aug; 15(6):781-90. PubMed ID: 1662403
    [Abstract] [Full Text] [Related]

  • 18. Pituitary-adrenal responses to combined oral D-fenfluramine and intravenous naloxone in humans.
    Grice JE, Torpy DJ, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
    Clin Exp Pharmacol Physiol; 1998 Aug; 25(7-8):621-3. PubMed ID: 9673439
    [Abstract] [Full Text] [Related]

  • 19. Higher n-3 fatty acids are associated with more intense fenfluramine-induced ACTH and cortisol responses among cocaine-abusing men.
    Buydens-Branchey L, Branchey M, Hibbeln JR.
    Psychiatry Res; 2011 Aug 15; 188(3):422-7. PubMed ID: 21658782
    [Abstract] [Full Text] [Related]

  • 20. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.
    Monteleone P, Tortorella A, Borriello R, Cassandro P, Maj M.
    Biol Psychiatry; 1999 Jun 15; 45(12):1606-11. PubMed ID: 10376122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.